Pulse Biosciences to Participate in Upcoming Investor Conferences
Pulse Biosciences, Inc. (Nasdaq: PLSE) has announced its participation in two upcoming virtual investor conferences. On March 10, 2021, management will engage in one-on-one meetings at the H.C. Wainwright Global Life Sciences Conference, with a presentation webcast available on March 9, 2021. Additionally, on March 17, 2021, the company will participate in an aesthetic dermatology panel discussion at the Maxim Emerging Growth Virtual Conference, featuring a live webcast at 2:00pm ET. Interested parties can access on-demand webcasts via the company’s website.
- None.
- None.
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced plans to participate in two upcoming virtual investor conferences.
Management is scheduled to participate in the H.C. Wainwright Global Life Sciences Conference hosting one-on-one meetings Wednesday, March 10, 2021. A presentation webcast will be available in advance of the event on Tuesday, March 9, 2021 at 7:00am ET.
Management is scheduled to participate in an aesthetic dermatology panel discussion during the Maxim Emerging Growth Virtual Conference on Wednesday, March 17, 2021. A live and recorded webcast of the panel discussion will be available at 2:00pm ET on the same day. A presentation by management will also be available at the start of the event at 9:00am ET on Wednesday, March 17, 2021.
Interested parties may access the on-demand webcasts from both conferences on the “Investors” section of the Company’s website at www.pulsebiosciences.com.
About Pulse Biosciences®
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The CellFX® System is the first commercial product to harness the distinctive advantages of the Company’s proprietary Nano-Pulse Stimulation™ (NPS™) technology, such as the ability to non-thermally clear cells while sparing non-cellular tissue, to treat a variety of applications for which an optimal solution remains unfulfilled. Nano-Pulse Stimulation technology delivers nano-second pulses of electrical energy. The initial commercial use of the CellFX System is to address a range of dermatologic conditions that share high demand among patients and practitioners for improved dermatologic outcomes. Designed as a multi-application platform, the CellFX System offers customer value with a utilization-based revenue model. To learn more, please visit pulsebiosciences.com.
To stay informed about the CellFX System, please visit CellFX.com and sign up for updates.
Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210305005107/en/
FAQ
What is the date of Pulse Biosciences' participation in the H.C. Wainwright Global Life Sciences Conference?
When will the webcast presentation for the H.C. Wainwright Conference be available?
What event will Pulse Biosciences attend on March 17, 2021?
What time will the live webcast for the Maxim Emerging Growth Virtual Conference panel discussion start?
Where can I find the on-demand webcasts for the investor conferences?
